Download 2009
Bohemian Medical Device Summit Agenda
Wednesday 09 December 2009
| 4:00 pm | Registration |
| 7:00 pm | Opening Reception |
Thursday 10 December 2009
| 7:30 am | Breakfast |
| 8:30 am | Introduction and Welcome |
| 8:45 am |
Corporate Spotlight A select group of European mid-sized companies continue to plot interesting strategies and execute on them effectively. In this session, the CEO of one such company sits down in a one-on-one interview to talk about the company’s recent moves and its plans going forward. Dr. Meinrad Lugan, Chairman of the Hospital Care division, B. Braun Melsungen AG Moderator: David Cassak, Elsevier |
| 10:00 am | Refreshment Break |
| 10:30 am |
Plotting Revolution Innovation is alive and well in Europe – this panel, made up of incubators and serial entrepreneurs, will discuss where the innovative technologies are coming from and how best to nurture them. Csaba Truckai, Founder, SurgRx Tor Peters, Co-Founder and Executive Chairman, NOLabs Chas Taylor, CEO, Veryan Medical, Ltd. Tim Lenihan, CEO, Medical Device Accelerator Moderator: Tracy Lefteroff, PricewaterhouseCoopers LLP |
| 11.45 am |
Movement Gains Momentum Good ideas need capital and other resources to make them flourish. This panel will look at current trends in venture funding, as well as alternative sources of capital and how best to be capital efficient in today’s climate. Tim Haines, Partner, Abingworth Dr. Beat Merz, Partner, Ares Life Sciences AG Antoine Papiernik, Managing Partner,Sofinnova Moderator: David Cassak, Elsevier |
| 12:30 pm | Lunch |
| 2:00 pm |
Looking for Love in all the Wrong Places Each stage of a company’s life has its own demands and challenges, no less so when a company achieves a hallmark of success, such as being acquired. In this panel we will examine the trials and tribulations of trade sale, from both sides of the fence. Mark Secrest, Managing Director, Cowen Group Peter Albrecht, Managing Director, Boston Scientific Technologie Zentrum Jeanne M. Forneris, VP Strategic Investments, CRDM Medtronic, Inc. Moderator: Berthold Hackl, CEO, invendo medical |
| 3:15 pm | Refreshment Break |
| 3:45 pm |
Company of the Year Award Each year, the Bohemian conference rewards one European company that has risen above all others in executing on its corporate strategy—either through a major trade sale, a successful IPO, or some other significant event. In this session, we talk with the people behind this year’s Award winner. |
| 7:00 pm | Summit Awards Dinner |
Friday 11 December 2009
| 7:30 am | Breakfast |
| 8:30 am |
Working with the Power Reimbursement and regulatory hurdles remain Ground Zero for medical device companies. Without a successful regulatory and reimbursement plan, no company will even begin to assess the commercial potential of its product. In this session, we look at the most recent trends and issues on the European reimbursement and regulatory landscape and offer practical advice for navigating through all of them. Jan van Lochem, Vice President Healthcare, British Standards Institute Sarah Sorrell, Founder & CEO, MedPass International Martin Jordan, Principal, Translucency Europe Ltd. Moderator: David Hoffmeisteir, Wilson Sonsini Goodrich & Rosati |
| 9:45 am | Refreshment Break |
| 10:30 am |
Learning from Adversity: Turning Around Troubled Companies Rarely is the path straight for even the most successful medical device company. From technology development mis-steps to strategic re-directions, regulatory obstacles to reimbursement roadblocks, few companies get to the finish line without having to deal with at least one major challenge. In this session, the CEOs of several companies talk about the challenges they faced and the decisions they made to put their companies on the path to success. Crispin Simon, CEO, Biocompatibles Oliver Bielenstein, CEO, ArthoKinetics André Michel Ballester, CEO, Sorin Group Moderator: Tim Haines, Abingworth |
| 11:15 am | Refreshment Break |
| 11:30 am |
Reading the Tea Leaves These are turbulent, uncertain times, not just for medical device companies, but for the global economy as well. In this session, a panel of industry experts offers their perspective on how to read the current climate and provides insights and answers to many of the questions—when will the IPO window open again, where is M&A headed, when will VCs start investing again—that are on the minds of medical device executives. Mark Secrest, Managing Director, Cowen Group Antoine Papiernik, Managing Partner, Sofinnova Tim Haines, Partner, Abingworth David Cassak, Managing Director, Elsevier Moderator: Casey McGlynn, Wilson Sonsini Goodrich & Rosati |
| 12:45 pm | Lunch and close |
